Anti-PSGL-1 Antikörper

European patent · EP2377890 · Deleted

Register entry

Publication number
EP2377890
Application number
EP11150345
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 10, 2005
Published
Oct 19, 2011
Granted
Aug 10, 2016
Deleted
May 10, 2025
Reason
Maximum term reached
IPC classes
C07K 16/28 (2006.01)
C07K 16/46 (2006.01)
C12N 15/13 (2006.01)
Priority
US 569892 P 10.05.2004
Divided from
EP05747985
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 10, 2025

    Maximum term reached

    Status of protective title
    Active → Cancelled
    Cancellation date
    10.05.2025
    Cause for cancellation
    Expiry of maximum term of protection

    Published in Swissreg on 10.05.2025

  2. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  3. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  4. Mar 5, 2021

    Transferred

    Owner
    AbGenomics Coöperatief U.A., Strawinskylaan 3111, 1077 ZX Amsterdam, Netherlands → AltruBio Inc., 1209 Orange Street, Wilmington, New Castle County, Delaware 19801, USA

    Published in Swissreg on 05.03.2021

  5. Aug 10, 2016

    Granted

    Published in Swissreg on 10.08.2016

Parties

Inventor

Lin, Rong-Hwa

Taipei 1, TW

Chang, Chung Nan

Foster City, CA 94404, US

Chen, Pei-Jiun

Taipei 234, TW

Huang, Chiu-Chen

Taipei 114, TW

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.